Skip to main content

Advertisement

SpringerLink
Log in

Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The role of hepatitis B virus (HBV) infection in patients with primary Sjögren's syndrome (pSS) remains unclear. Therefore, we investigated the prevalence and clinical significance of HBV infection in Taiwanese patients with pSS. One hundred seventy-five patients with pSS who fulfilled the 2002 American-European Revised Classification Criteria were enrolled. Eighteen (10.3%) patients were positive for hepatitis B surface antigen (HBsAg). There were 4 males and 14 females, with the mean age of 54.4 years. The main immunological feature was rheumatoid factor (13 of 18, 72.2%), which was significantly higher than those negative for HBsAg (28.1%, p < 0.001). Twelve (66.7%) patients developed liver dysfunction, which was significantly different from the 15.3% of patients who were negative for HBsAg (p < 0.001). There was no significant difference in extraglandular features between patients positive and negative for HBsAg, except patients positive for HBsAg had a lower rate to develop pulmonary involvement than those negative for HBsAg (5.6% vs. 29.9%, p = 0.027). The mortality rate of pSS patients positive for HBsAg during follow-up was 12.0% and the presence of HBV infection did not influence the survival rate (p = 0.730). pSS patients with liver cirrhosis presented shorter median overall survival compared to those with without liver cirrhosis (p < 0.001). Our findings suggest that HBV infection may protect individuals from pSS and reduce pulmonary involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Merican I, Guan R, Amarapuka D et al (2000) Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15:1356–1361

    Article  PubMed  CAS  Google Scholar 

  2. Santini GF, Crovatto M, Giannini F et al (1998) Hepatitis C virus and immunoglobulin gene rearrangements: an early step in lymphomagenesis? Acta Haematol 100:117–122

    Article  PubMed  CAS  Google Scholar 

  3. Sung JL (1997) Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 12:S370–S376

    Article  PubMed  CAS  Google Scholar 

  4. Chuang WL, Chang WY, Lu SN et al (1992) The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case–control study. Cancer 69:2052–2054

    Article  PubMed  CAS  Google Scholar 

  5. Thong BYH, Koh ET, Chng HH et al (2007) Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases. Ann Acad Med Singapore 36:100–105

    PubMed  Google Scholar 

  6. Maya R, Gershwin ME, Shoenfeld Y (2008) Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allerg Immunol 34:85–102

    Article  Google Scholar 

  7. Ramos-Casals M, Tzioufas AG, Font J (2005) Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 64:347–354

    Article  PubMed  CAS  Google Scholar 

  8. Ram M, Anaya JM, Barzilai O et al (2008) The putative protective role of hepatitis B virus (HBV) infection against autoimmune disorders. Autoimmun Rev 7:621–625

    Article  PubMed  CAS  Google Scholar 

  9. Fox RI (2005) Sjögren's syndrome. Lancet 366:321–331

    Article  PubMed  CAS  Google Scholar 

  10. Ramos-Casals M, García-Carrasco M, Cervera R et al (2001) Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine 80:1–8

    Article  PubMed  CAS  Google Scholar 

  11. Arrieta JJ, Rodriguez-Iñigo E, Ortiz-Movilla N et al (2001) In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 158:259–264

    Article  PubMed  CAS  Google Scholar 

  12. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558

    Article  PubMed  CAS  Google Scholar 

  13. Marcos M, Alvarez F, Brito-Zerón P et al (2009) Chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients. Autoimmun Rev 8:616–620

    Article  PubMed  Google Scholar 

  14. Chen CH, Yang PM, Huang GT et al (2007) Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatic screening participants. J Formos Med Assoc 106:148–155

    Article  PubMed  Google Scholar 

  15. Musset L, Diemert MC, Taibi F et al (1992) Characterization of cryoglobulins by immunoblotting. Clin Chem 38:798–802

    PubMed  CAS  Google Scholar 

  16. Brouet JC, Clauvel JP, Danon F, Seligmann M et al (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57:775–788

    Article  PubMed  CAS  Google Scholar 

  17. Lee IC, Huang YH, Chan CC et al (2010) Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein. Liver Int 30:1161–1168

    Article  PubMed  CAS  Google Scholar 

  18. Lok AS, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50:661–662

    Article  PubMed  Google Scholar 

  19. Huang YH, Chen CH, Chang TT et al (2004) The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Liver Int 24:419–424

    Article  PubMed  Google Scholar 

  20. Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938

    Article  PubMed  CAS  Google Scholar 

  21. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273

    Article  PubMed  CAS  Google Scholar 

  22. Ferri C, SebastianiM GD et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33:355–374

    Article  PubMed  Google Scholar 

  23. Trejo O, Ramos-Casals M, Garcia-Carrasco M et al (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80:252–262

    Article  CAS  Google Scholar 

  24. Kivity S, Agmon-Levin N, Blank M et al (2009) Infections and autoimmunity—friends or foes? Trends Immunol 30:409–414

    Article  PubMed  CAS  Google Scholar 

  25. Lu CL, Tsai ST, Chan CY et al (1997) Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan. Gastroenterol Hepatol 12:272–276

    Article  CAS  Google Scholar 

  26. Zhao J, Qiu M, Li M et al (2010) Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China. Rheumatol Int 30:1565–1570

    Article  PubMed  Google Scholar 

  27. Okada H, Kuhn C, Feillet H et al (2010) The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol 160:1–9

    Article  PubMed  CAS  Google Scholar 

  28. Koski H, Janin A, Humphreys-Beher MG et al (2001) Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome. Clin Exp Rheumatol 19:131–137

    PubMed  CAS  Google Scholar 

  29. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920

    Article  PubMed  Google Scholar 

  30. Wakamatsu E, Matsumoto I, Yasukochi T et al (2006) Overexpression of phosphorylated STAT-1alpha in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 54:3476–3484

    Article  PubMed  CAS  Google Scholar 

  31. Liu J, Yang HI, Lee MH et al (2010) Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 139:474–482

    Article  PubMed  Google Scholar 

  32. Ramos-Casals M, Loustaud-Ratti V, De Vita S, SS-HCV Study Group et al (2005) Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84:81–89

    Article  Google Scholar 

  33. Strimlan CV, Rosenow EC 3rd, Divertie MB et al (1976) Pulmonary manifestations of Sjögren's syndrome. Chest 70:354–361

    Article  PubMed  CAS  Google Scholar 

  34. Deheinzelin D, Capelozzi VL, Kairalla RA et al (1996) Interstitial lung disease in primary Sjögren's syndrome. Clinical–pathological evaluation and response to treatment. Am J Respir Crit Care Med 154:794–799

    PubMed  CAS  Google Scholar 

  35. Webster GJ, Reignat S, Brown D et al (2004) Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 78:5707–5719

    Article  PubMed  CAS  Google Scholar 

  36. Ge J, Wang K, Meng QH et al (2010) Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 30:60–67

    Article  PubMed  CAS  Google Scholar 

  37. Meijer JM, Meiners PM, Vissink A et al (2010) Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62:960–968

    Article  PubMed  CAS  Google Scholar 

  38. Elkon KB, Gharavi AE, Hughes GR et al (1984) Autoantibodies in the sicca syndrome (primary Sjögren's syndrome). Ann Rheum Dis 43:243–245

    Article  PubMed  CAS  Google Scholar 

  39. Watanabe K, Ohkubo Y, Funahashi Y et al (1991) An investigation on rheumatoid factor of different immunoglobulin classes in hepatitis B virus carriers. Clin Rheumatol 10:31–37

    Article  PubMed  CAS  Google Scholar 

  40. Yeh HM, Chiang W, Chen SF et al (1994) Rheumatoid factor in hepatitis B virus surface antigen positive patients. Gaoxiong Yi Xue Ke Xue Za Zhi 10:239–243

    PubMed  CAS  Google Scholar 

  41. Karp JK, Akpek EK, Anders RA (2010) Autoimmune hepatitis in patients with primary Sjögren's syndrome: a series of two-hundred and two patients. Int J Clin Exp Pathol 3:582–586

    PubMed  Google Scholar 

  42. Lindgren S, Manthorpe R, Eriksson S (1994) Autoimmune liver disease in patients with primary Sjögren's syndrome. J Hepatol 20:354–358

    Article  PubMed  CAS  Google Scholar 

  43. Rihl M, Ulbricht K, Schmidt RE et al (2009) Treatment of sicca symptoms with hydroxychloroquine in patients with Sjögren's syndrome. Rheumatology 48:796–799

    Article  PubMed  CAS  Google Scholar 

  44. Makin AJ, Wendon J, Fitt S et al (1994) Fulminant hepatic failure secondary to hydroxychloroquine. Gut 35:569–570

    Article  PubMed  CAS  Google Scholar 

  45. Giner Galvañ V, Oltra MR, Rueda D et al (2007) Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease. Clin Rheumatol 26:971–972

    Article  PubMed  Google Scholar 

  46. Nair PV, Tong MJ, Stevenson D et al (1985) Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. Liver 5:8–12

    PubMed  CAS  Google Scholar 

  47. Scullard GH, Smith CI, Merigan TC et al (1981) Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 81:987–991

    PubMed  CAS  Google Scholar 

  48. Lubel JS, Testro AG, Angus PW (2007) Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Intern Med J 37:705–712

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Division of Allergy, Immunology, and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei, 11217, Taiwan

    Ming-Han Chen, Chang-Youh Tsai & Chung-Tei Chou

  2. Department of Medicine, Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

    Ming-Han Chen, Liang-Tsai Hsiao, Ming-Huang Chen, Chang-Youh Tsai, Yi-Hsiang Huang & Chung-Tei Chou

  3. Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

    Yi-Hsiang Huang

Authors
  1. Ming-Han Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liang-Tsai Hsiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ming-Huang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chang-Youh Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi-Hsiang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chung-Tei Chou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chung-Tei Chou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, MH., Hsiao, LT., Chen, MH. et al. Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome. Clin Rheumatol 31, 309–315 (2012). https://doi.org/10.1007/s10067-011-1814-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1814-2

Keywords

Search

Navigation